NOXY HEALTH PRODUCTS, INC. – Trademark Portfolio
Entity Type: 03
NOXY HEALTH PRODUCTS, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include NOXY, ADVANOX, NOXYDERM, NOXY FOAM, and NOXY HEALTH PRODUCTS. The owner is based in Anaconda, MT.
118 East 7th St. Suite 2M
Anaconda, MT 59711
Showing of trademarks Trademarks
Trademark Classifications
NOXY HEALTH PRODUCTS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does NOXY HEALTH PRODUCTS, INC. have?
NOXY HEALTH PRODUCTS, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned.
What trademark classes does NOXY HEALTH PRODUCTS, INC. file in?
NOXY HEALTH PRODUCTS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NOXY HEALTH PRODUCTS, INC.'s most well-known trademarks?
NOXY HEALTH PRODUCTS, INC.'s registered trademark portfolio includes well-known marks such as NOXY, ADVANOX, NOXYDERM, NOXY FOAM, and NOXY HEALTH PRODUCTS. These are among 5 currently registered trademarks in the portfolio.
What is NOXY HEALTH PRODUCTS, INC.'s trademark registration success rate?
NOXY HEALTH PRODUCTS, INC. has a 71% trademark registration rate, with 5 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.